Abattis Bioceuticals Archives

Abattis Bioceuticals to Dispose of Cannabis Operations

Abattis Bioceuticals (CSE: ATT) is leaving the cannabis business for good. The announcement came late Friday night from the troubled

Abattis Bioceuticals Corp. (CSE: ATT) appears to have avoided delisting from the Canadian Securities Exchange, if only narrowly. The equity

Abattis Bioceuticals Corp (CSE: ATT) is to delist from the Canadian Securities Exchange. The reason behind the delisting is related

Just before the Easter long weekend, it was announced that Abattis Bioceuticals Corp (CSE: ATT) was to be flagged by